UK genetic discovery programme for eight major diseases gets £9m boost:
This article was originally published in Clinica
Executive Summary
UK researchers have received a £9m ($15.8) grant to begin a nationwide study to identify genetic variants that might predispose people to eight major diseases. The three-year project, which has received funding from the Wellcome Trust, will analyse and identify genetic markers for tuberculosis, coronary heart disease, type-1 and type-2 diabetes, rheumatoid arthritis, Crohn's disease, bipolar disorder and hypertension. Researchers from the Wellcome Trust Case Control Consortium (WTCCC) - a collaboration of 24 leading human geneticists - will analyse over 19,000 DNA samples for 675,00 genetics points where key variations are thought to occur. The study will be conducted at various institutes and universities throughout the UK, including the Wellcome Trust Sanger Institute, Cambridge University and Oxford University.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.